Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other ...

Biotechnology has emerged as a driving force in transforming healthcare. Over the past few decades, the integration of biology with advanced technology has led to significant breakthroughs. These ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

AI will deliver transformative therapies at an exponential scale, addressing the complexities of biology that traditional ...

Fintel reports that on May 27, 2025, HC Wainwright & Co. downgraded their outlook for Unity Biotechnology (NasdaqGS:UBX) from ...

The Cocoon® (from Lonza) is a functionally closed, sterile, efficient manufacturing platform, which combined with our ...

Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 46th Annual Global ...

In a world shaped by biotechnology, why are so few college students exposed to its possibilities early on in their education?

Western drugmakers, investors increasingly aim to acquire Chinese compounds.

In this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical ...

MAIA Biotechnology, Inc. (NYSE:MAIA), a clinical-stage biopharmaceutical company, has announced a private placement agreement ...